[Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
作者信息
Ringe Johann D
出版信息
MMW Fortschr Med. 2009 Mar 5;151(10):7.
PMID:19472655
Abstract
摘要
相似文献
1
[Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
MMW Fortschr Med. 2009 Mar 5;151(10):7.
2
[Osteoporosis and bisphosphonates].
Z Rheumatol. 2007 Dec;66(8):713-5. doi: 10.1007/s00393-007-0227-8.
3
Yearly zoledronic acid in postmenopausal osteoporosis.
N Engl J Med. 2007 Aug 16;357(7):712-3; author reply 714-5.
4
Bisphosphonates and atrial fibrillation.
Prescrire Int. 2008 Aug;17(96):161.
5
A once-yearly IV bisphosphonate for osteoporosis.
Med Lett Drugs Ther. 2007 Nov 5;49(1273):89-90.
6
[Diphosphonate therapy and osteonecrosis of the jaw].
Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1945-7.
7
Atrial fibrillation following intravenous zolendronic acid for osteoporosis.
J Clin Rheumatol. 2014 Jun;20(4):239-40. doi: 10.1097/RHU.0000000000000114.
8
Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study.
Calcif Tissue Int. 2010 May;86(5):335-42. doi: 10.1007/s00223-010-9349-0. Epub 2010 Mar 23.
9
Alendronate and atrial fibrillation.
N Engl J Med. 2007 May 3;356(18):1895-6. doi: 10.1056/NEJMc076132.
10
Yearly zoledronic acid in postmenopausal osteoporosis.
N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5.
Zotero 插件